tradingkey.logo
tradingkey.logo
Search

Protagonist Therapeutics Takeda To Lead Regulatory Strategy For Rusfertide In Polycythemia Vera NDA

ReutersMar 20, 2025 8:58 PM
facebooktwitterlinkedin

- Protagonist Therapeutics Inc PTGX.O:

  • PROTAGONIST THERAPEUTICS- TAKEDA TO LEAD REGULATORY STRATEGY FOR RUSFERTIDE IN POLYCYTHEMIA VERA NDA

  • PROTAGONIST THERAPEUTICS INC - TRANSITION TO TAKEDA OF LEADERSHIP FOR NDA PREPARATION UNDERWAY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI